搜索页_+HER2-positive

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：992条，耗时：0.0359803 秒

在所有数据库中总计命中：9,891条

1.More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials

作者：A. Vasista^a ; ^c ; M.R. Stockler^a ; ^b ; T. West^b ; N. Wilcken^b ; ^c ; B.E. Kiely^a ; ^{belinda.kiely@ctc.usyd.edu.au}

关键词：Estimating survival times ; HER2-positive ; Metastatic breast cancer

刊名：The Breast

出版年：2017

2.Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells

作者：Sandeep Pallerla^a ; Ted Gauthier^b ; Rushikesh Sable^a ; Seetharama D. Jois^a ; ^jois@ulm.edu

关键词：HER2 ; Lung cancer ; Breast cancer ; Doxorubicin ; Peptidomimetic ; Conjugate

刊名：European Journal of Medicinal Chemistry

出版年：2017

3.Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

作者：John W. Smith II¹ ; ² ; Marc E. Buyse³ ; Priya Rastogi¹ ; ⁴ ; ^{rastogip@upmc.edu} ; Charles E. Geyer Jr.¹ ; ⁵ ; Samuel A. Jacobs¹ ; ⁴ ; Erica J. Patocskai¹ ; ⁶ ; André ; Robidoux¹ ; ⁶ ; Alison K. Conlin¹ ; ⁷ ; Bilal Ansari¹ ; ⁸ ; George P. Keogh¹ ; ⁹ ; Philip J. Stella¹ ; ¹⁰ ; Howard M. Gross¹ ; ¹¹ ; Raymond S. Lord¹ ; ¹² ; Jonathan A. Polikoff¹ ; ¹³ ; Celine Mauquoi³ ; Eleftherios P. Mamounas¹ ; ¹⁴ ; Sandra M. Swain¹ ; ¹⁵ ; ¹⁶ ; Norman Wolmark¹ ; ¹⁷

关键词：Neoadjuvant chemotherapy

刊名：Clinical Breast Cancer

出版年：2017

4.Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol

作者：Kadoaki Ohashi¹ ; ^{kohashi@cc.okayama-u.ac.jp} ; Katsuyuki Hotta² ; Taizo Hirata² ; Keisuke Aoe³ ; Toshiyuki Kozuki⁴ ; Kiichiro Ninomiya⁵ ; Hiroe Kayatani⁵ ; Hiroyuki Yanai⁶ ; Shinichi Toyooka⁷ ; Shiro Hinotsu² ; Minoru Takata⁸ ; Katsuyuki Kiura¹

关键词：HER2 amplification ; HER2 mutations ; HER2 over-expression ; NSCLC ; Trastuzumab emtansine

刊名：Clinical Lung Cancer

出版年：2017

5.Transcriptional repression of HER2 by ANO1 Cl⁻ channel inhibition in human breast cancer cells with resistance to trastuzumab

作者：Mayu Fujimoto^a ; ¹ ; Takahiro Inoue^a ; ¹ ; Hiroaki Kito^a ; Satomi Niwa^a ; Takayoshi Suzuki^b ; Katsuhiko Muraki^c ; Susumu Ohya^a ; ^{sohya@mb.kyoto-phu.ac.jp}

关键词：Breast cancer ; HER2 ; Resistance to HER2-targeted therapy ; Ca2+-activated Cl&minus ; channel ; ANO1 ; IGFBP5

刊名：Biochemical and Biophysical Research Communications

出版年：2017

6.Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

作者：Makiko Ono¹ ; ² ; Hitoshi Tsuda³ ; ⁴ ; ^{htsuda@ndmc.ac.jp} ; Masayuki Yoshida⁴ ; Chikako Shimizu² ; Takayuki Kinoshita⁵ ; Kenji Tamura²

关键词：Cutoff ; Luminal subtype ; PR ; Prognostic factor ; Tumor size

刊名：Clinical Breast Cancer

出版年：2017

7.A potential pitfall in evaluating HER2 immunohistochemistry for gastric signet ring cell carcinomas

作者：Chang Gok Woo¹ ; ^&lowast ; ; Won Jin Ho² ; ^&lowast ; ; Young Soo Park³ ; ^{youngspark@amc.seoul.kr} ; Sook Ryun Park⁴ ; Min-Hee Ryu⁴ ; Hwoon-Yong Jung⁵ ; Yoon-Koo Kang⁴

关键词：Gastric cancer ; signet ring cell carcinoma ; immunohistochemistry ; HER2 ; trastuzumab

刊名：Pathology

出版年：2017

8.Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide

作者：Zhichu Xiang^a ; ^b ; ^c ; ^d ; Xiaoliang Yang^a ; ^b ; ^d ; Junjie Xu^f ; Wenjia Lai^a ; ^b ; Zihua Wang^a ; ^b ; ^d ; Zhiyuan Hu^a ; ^b ; ^{huzy@nanoctr.cn} ; Jiesheng Tian^f ; ^{tianhome@cau.edu.cn} ; Lingling Geng^a ; ^e ; ^{linggengling@163.com} ; Qiaojun Fang^a ; ^b ; ^{fangqj@nanoctr.cn}

关键词：EGFR/HER2 targeting peptide ; Molecular dynamics (MD) simulation ; Magnetosome ; Targeted MRI ; Breast cancer

刊名：Biomaterials

出版年：2017

9.Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

作者：Stephen J Luen ; MBChB^a ; Roberto Salgado ; MD^b ; ^c ; Prof Stephen Fox ; PhD^a ; Peter Savas ; MBBS^a ; Jennifer Eng-Wong ; MD^d ; Emma Clark ; MSc^e ; Astrid Kiermaier ; PhD^f ; Sandra M Swain ; MD^g ; Jose Baselga ; MD^h ; Stefan Michiels ; PhDⁱ ; Dr Sherene Loi ; MD^a ; ^{sherene.loi@petermac.org}

刊名：The Lancet Oncology

出版年：2017

10.Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinoma

作者：Fresia Pareja ; MD ; PhD^a ; Melissa P. Murray ; DO^a ; Ryan Des Jean ; MD^b ; Fumiko Konno ; MD^a ; Maria Friedlander ; MPA ; CT (ASCP)^a ; Oscar Lin ; MD ; PhD^a ; Marcia Edelweiss ; MD^a ; ^{edelweim@mskcc.org}

关键词：Estrogen receptor ; Progesterone receptor ; HER2 ; Cytology ; FNA ; Metastasis ; Breast cancer

刊名：Journal of the American Society of Cytopathology

出版年：2017

按检索点细分(992)

题名(382)

关键词(44)

文摘(701)

按出版年细分(992)

2027年及以后(78)

2017年(21)

2016年(146)

2015年(88)

2013年(121)

2012年(103)

2011年(92)

2010年(71)

2009年(48)

2008年(52)

2007年(45)

2006年(26)

2005年(29)

2004年(22)

2003年(11)

2002年(8)

2001年(14)

2000年(6)

2000年及以前(11)